Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1979-04-13
1981-10-27
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
424 15, 424 12, 23230B, G01N 3348, G01T 100
Patent
active
042973376
ABSTRACT:
Solid-phase immunoassay procedures employing magnetic glass or crystal-containing material, or a superparamagnetic material formed of magnetic particles dispersed in a non-magnetic matrix, as particulate carrier.
REFERENCES:
patent: 3555143 (1971-01-01), Axen et al.
patent: 3652761 (1972-03-01), Weetall
patent: 3654090 (1972-04-01), Schuurs et al.
patent: 3933997 (1976-01-01), Hersh et al.
patent: 3940475 (1976-02-01), Gross
patent: 3970518 (1976-07-01), Giaever
patent: 3985649 (1976-10-01), Eddelman
patent: 4018886 (1977-04-01), Giaever
patent: 4098876 (1978-07-01), Piassio et al.
patent: 4115534 (1978-09-01), Ithakissios
patent: 4177253 (1979-12-01), Davies et al.
Immobilized Enzymes for Industrial Reactors, R. A. Messing, Ed., Academic Press, NY, 1975, pp. 39-61.
Nye et al., Clin. Chim. Acta, 69, 387 (1976).
Ithakissios et al., Clin. Chim. Acta, 84, 69 (1978).
Ithakissios et al., Clin. Chem., 23, 2072 (1977).
Mansfield Gerald R.
Travis Karen L.
Vann William P.
Corning Glass Works
Maycock Willim E.
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Solid-phase immunoassays using magnetic glass does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Solid-phase immunoassays using magnetic glass, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Solid-phase immunoassays using magnetic glass will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-279311